Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight ...

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white blood ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 infections than with ...

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

A RECENT study has highlighted the potential of using peripheral blood absolute lymphocyte count (ALC) as a biomarker for assessing immune status and predicting survival outcomes in multiple myeloma ...

On the basis of the data presented from the MM-009 and MM-010 trials, FDA approved lenalidomide for use in combination with dexamethasone in patients with MM who have received one prior therapy ...

In April 2017, Glenn Hussey went to The Ottawa Hospital for a regular checkup to monitor his smouldering multiple myeloma ... (Nick Persaud/CBC) According to Dr. Sandy Sehdev, an oncologist ...

In April 2017, Glenn Hussey went to The Ottawa Hospital for a regular checkup to monitor his smouldering multiple myeloma — a precursor to the rare blood plasma cancer multiple myeloma.

As detailed previously, patient education is of paramount importance for the appropriate and safe use of lenalidomide. Patients should be counseled in detail about the risks of fetal exposure to ...